Real-world healthcare utilization and costs of peripheral nerve stimulation with a micro-IPG system.

ABSTRACT:

Aim

To characterize real-world healthcare resource utilization (HCRU) and costs in adults with chronic pain of peripheral nerve origin treated with peripheral nerve stimulation (PNS) using the micro-implantable pulse generator (IPG).

Materials & methods

This retrospective observational study (9/1/19-1/31/23) linked patients from the Nalu medical database to the OM1 Real-World Data Cloud (RWDC). Eligible patients received the micro-IPG implant for PNS, were identifiable in both databases, and had ≥ 12 months of RWDC pre/post-implantation claims data. Primary outcomes were all-cause HRCU and medical costs (12 months pre- and post-implantation); secondary outcomes were all-cause pharmacy costs, including opioids, over the same time.

Results

Patients (N = 122) had

SUBMITTER: Kalia H 

PROVIDER: S-EPMC11801342 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature